Quarterly report pursuant to Section 13 or 15(d)

CAPITAL STOCK AND STOCKHOLDERS' EQUITY (Details Narrative)

v3.8.0.1
CAPITAL STOCK AND STOCKHOLDERS' EQUITY (Details Narrative) - USD ($)
$ / shares in Units, $ in Thousands
1 Months Ended 2 Months Ended 9 Months Ended
Sep. 12, 2017
Jul. 31, 2017
Sep. 30, 2017
Apr. 30, 2017
Mar. 31, 2017
Apr. 30, 2017
Sep. 30, 2017
Jun. 30, 2017
Dec. 31, 2016
Number of shares issued upon conversion     223,585       223,585    
Preferred stock, par value (in dollars per share)     $ 0.0001       $ 0.0001   $ 0.0001
Exchange Agreement [Member] | Investors [Member]                  
Principal amount of senior convertible debentures $ 2,500,000                
Lewis & Clark Pharmaceuticals, Inc. [Member]                  
Stock issued during period, shares   7,122,172              
Percentage of shares acquired   100.00%              
Warrant [Member]                  
Number of common shares purchased     800,019       800,019 800,019  
Common Stock [Member]                  
Number of shares converted     331,000            
Amount of shares converted     $ 37,995            
Number of conversion convertible debentures (in shares)             223,585    
Series C 0% Convertible Preferred Stock [Member]                  
Stock issued during period, shares       90.4 290.4        
Value of number of shares issued         $ 200        
Conversion price (in dollars per share)       $ 0.75 $ 0.75        
Number of shares issued upon conversion     387,251 120,578   120,578 387,251    
Number of common shares purchased               266,673  
Preferred stock, par value (in dollars per share)     $ 1,000 $ 1,000   $ 1,000 $ 1,000 $ 1,000  
Securities sold       90,431          
Series M Common Stock Purchase Warrants [Member]                  
Exercise price (in dollars per share)       $ 0.90   $ 0.90   $ 0.90  
Warrant expiration period       5 years 5 years 5 years      
Number of shares issued upon conversion       120,578   120,578      
Number of common shares purchased       387,251   387,251   266,673  
Series N Common Stock Purchase Warrants [Member]                  
Exercise price (in dollars per share)       $ 0.75   $ 0.75   $ 0.75  
Warrant expiration period       6 months 6 months 6 months      
Number of shares issued upon conversion       120,578   120,578      
Number of common shares purchased       387,251   387,251   266,673  
Series O Common Stock Purchase Warrants [Member]                  
Exercise price (in dollars per share)       $ 0.75   $ 0.75   $ 0.75  
Warrant expiration period       12 months 12 months 12 months      
Number of shares issued upon conversion       120,578   120,578      
Number of common shares purchased       387,251   387,251   266,673  
Series A Preferred Stock [Member]                  
Number of shares converted             79.5    
Series A Preferred Stock [Member] | Exchange Agreement [Member] | Series A 0% Convertible Preferred Stock [Member] | Investors [Member]                  
Number of shares converted 1,614.8125                
Amount of shares converted $ 1,600,000                
Series B Preferred Stock [Member]                  
Exercise price (in dollars per share)     $ 0.08       $ 0.08    
Number of shares converted             39    
Series B Preferred Stock [Member] | Exchange Agreement [Member] | Series B 0% Convertible Preferred Stock [Member] | Investors [Member]                  
Number of shares converted 890